CAR 70-BCMA CAR-T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR 70-BCMA CAR-T Cells, covering 2026-04-09 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms [EARLY_Phase 1]